Codelivery of Doxorubicin/PI3K Inhibitor Nanomicelle Linked with Phenylboronic Acid for Enhanced Cytotoxicity to Pancreatic Cancer

Figure 4

DOX (a) and PF (b) release of PF@PPD NPs in 48 hours.

(a)

(b)